Latest Breaking News On - Sarepta therapeutics daily - Page 13 : comparemela.com

Royal Bank of Canada Lowers Sarepta Therapeutics (NASDAQ:SRPT) Price Target to $151 00

Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its target price dropped by equities research analysts at Royal Bank of Canada from $155.00 to $151.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the biotechnology company’s stock. Royal Bank of Canada’s price objective points […]

Richard barryDouglass ingramMontaga associates incDeutsche bank aktiengesellschaftRoyal bankMorgan stanleyFirst horizon advisors incSarepta therapeutics incPartners investment advisoryJpmorgan chase coKb financial partnersSarepta therapeuticsGet free reportBank aktiengesellschaftDirector richard barryWealth management

Capula Management Ltd Makes New Investment in Sarepta Therapeutics, Inc (NASDAQ:SRPT)

Capula Management Ltd bought a new position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm bought 11,627 shares of the biotechnology company’s stock, valued at approximately $1,409,000. Other hedge funds and other institutional investors have also modified their holdings of […]

Douglass ingramRichard barryCantor fitzgeraldDimensional fund advisorsFinancial services group incMetlife investment managementHealthcare of ontario pension plan trust fundSarepta therapeutics company profileGreat west life assurance coSarepta therapeutics incCapula management ltdNeedham companySarepta therapeuticsFree reportServices groupOntario pension plan trust fund

Sarepta Therapeutics, Inc (NASDAQ:SRPT) Given Average Rating of Moderate Buy by Analysts

Sarepta Therapeutics, Inc (NASDAQ:SRPT) Given Average Rating of Moderate Buy by Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandDouglass ingramRichard barryWellington management groupPrudential financial incMorgan stanleyNeedham companyYork mellon corpPricet rowe associates incSarepta therapeutics incNorges bankSarepta therapeuticsGet free reportMarketbeat ratingsDirector richard barry

Zacks Research Brokers Raise Earnings Estimates for Sarepta Therapeutics, Inc (NASDAQ:SRPT)

Zacks Research Brokers Raise Earnings Estimates for Sarepta Therapeutics, Inc (NASDAQ:SRPT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandRichard barryDouglass ingramHandelsinvest investeringsforvaltningVanguard group incZacks researchRoyal bankSarepta therapeutics incSarepta therapeutics company profileWellington management groupSarepta therapeuticsFree reportSarepta therapeuticGet free reportTherapeutics stock down

Q3 2024 Earnings Estimate for Sarepta Therapeutics, Inc Issued By Zacks Research (NASDAQ:SRPT)

Q3 2024 Earnings Estimate for Sarepta Therapeutics, Inc Issued By Zacks Research (NASDAQ:SRPT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandDouglass ingramRichard barrySarepta therapeutics company profileSarepta therapeutics incSecurities exchange commissionZacks researchWellington management groupBlackrock incRoyal bankMorgan stanleyYork mellon corpVanguard group incSarepta therapeuticsFree report